376 related articles for article (PubMed ID: 38201569)
1. Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer.
Yokoi R; Tajima JY; Fukada M; Hayashi H; Kuno M; Asai R; Sato Y; Yasufuku I; Kiyama S; Tanaka Y; Murase K; Matsuhashi N
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201569
[TBL] [Abstract][Full Text] [Related]
2. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.
Wild AT; Yamada Y
Visc Med; 2017 Mar; 33(1):54-61. PubMed ID: 28612018
[TBL] [Abstract][Full Text] [Related]
3. Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials.
Izmailov T; Ryzhkin S; Borshchev G; Boichuk S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958408
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
Seo YS; Kim MS; Yoo HJ; Jang WI
World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
[TBL] [Abstract][Full Text] [Related]
5. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Carconi C; Cerreti M; Roberto M; Arrivi G; D'Ambrosio G; De Felice F; Di Civita MA; Iafrate F; Lucatelli P; Magliocca FM; Picchetto A; Picone V; Catalano C; Cortesi E; Tombolini V; Mazzuca F; Tomao S
Crit Rev Oncol Hematol; 2023 Jun; 186():103990. PubMed ID: 37061075
[TBL] [Abstract][Full Text] [Related]
6. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
[TBL] [Abstract][Full Text] [Related]
7. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
8. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
Sheikh S; Chen H; Sahgal A; Poon I; Erler D; Badellino S; Dagan R; Foote MC; Louie AV; Redmond KJ; Ricardi U; Biswas T
Radiother Oncol; 2022 Feb; 167():187-194. PubMed ID: 34952002
[TBL] [Abstract][Full Text] [Related]
9. Novel insights of oligometastases and oligo-recurrence and review of the literature.
Niibe Y; Chang JY
Pulm Med; 2012; 2012():261096. PubMed ID: 22966429
[TBL] [Abstract][Full Text] [Related]
10. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
11. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
Yamashita H; Niibe Y; Yamamoto T; Katsui K; Jingu K; Kanazawa S; Terahara A; Nakagawa K
Jpn J Clin Oncol; 2016 Jul; 46(7):687-91. PubMed ID: 27162324
[TBL] [Abstract][Full Text] [Related]
12. [Local ablative radiotherapy of oligometastatic colorectal cancer].
Petersen C; Gauer T
Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
[TBL] [Abstract][Full Text] [Related]
13. A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland.
Sharrett J; Pederson A
Cureus; 2015 Dec; 7(12):e438. PubMed ID: 26858919
[TBL] [Abstract][Full Text] [Related]
14. Oligometastatic Disease Management: Finding the Sweet Spot.
Szturz P; Nevens D; Vermorken JB
Front Oncol; 2020; 10():617793. PubMed ID: 33415080
[TBL] [Abstract][Full Text] [Related]
15. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
16. Oligometastasis and oligo-recurrence: more than a mirage.
Huang F; Wu G; Yang K
Radiat Oncol; 2014 Oct; 9():230. PubMed ID: 25359216
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.
Ricardi U; Badellino S; Filippi AR
J Radiat Res; 2016 Aug; 57(S1):i58-i68. PubMed ID: 26962198
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
[TBL] [Abstract][Full Text] [Related]
19. The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies.
Massaut E; Bohlok A; Lucidi V; Hendlisz A; Klastersky JA; Donckier V
Curr Opin Oncol; 2018 Jul; 30(4):262-268. PubMed ID: 29746284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
